Appendiceal carcinoid tumor is the most common neoplasm of the appendix, accounting for 50-70% of all appendiceal tumors. It originates from neuroendocrine cells (enterochromaffin cells / Kulchitsky cells). Annual incidence is 0.15-0.6 per 100,000, and it is found incidentally in 0.3-0.9% of appendectomy specimens. Slightly more common in females than males (F:M = 1.5:1) with a mean age at diagnosis of 40-50. Seventy to eighty percent of tumors are located at the appendiceal tip (distal end) — this anatomical preference is due to the highest concentration of enterochromaffin cells in the submucosa of the distal appendix. The vast majority (95%) are smaller than 2 cm and are treated with appendectomy alone. Overall 5-year survival exceeds 95%. Carcinoid syndrome occurs in less than 1% of appendiceal carcinoids — this low rate is explained by first-pass hepatic metabolism of serotonin produced by the tumor via portal circulation. However, tumors >2 cm, mesoappendix invasion, or lymphovascular invasion increase metastasis risk and warrant right hemicolectomy.
Age Range
20-60
Peak Age
40
Gender
Female predominant
Prevalence
Uncommon
Appendiceal carcinoid tumor originates from enterochromaffin cells (Kulchitsky cells) in the submucosa — these cells synthesize serotonin, chromogranin A, and other neuropeptides. Tumor cells have round, uniform nuclei and fine granular cytoplasm (well-differentiated morphology). Growth pattern is typically solid islands and trabecular structures. The tumor begins in the submucosa and progresses toward the muscularis propria — this submucosal origin appears as a well-defined, homogeneously enhancing intramural nodule on CT/MRI. The characteristic hypervascularity of neuroendocrine tumors (dense capillary network) explains the prominent arterial phase enhancement — tumor cells secrete VEGF and create intense neovascularization. The preferential location at the appendiceal tip is because enterochromaffin cell density is highest in this region (embryological midgut-hindgut junction). When <2 cm, the tumor generally remains confined to the appendiceal wall with metastasis risk below 2%. However, in tumors >2 cm, metastasis to mesoappendix fat, lymph nodes, and rarely liver may occur (10-30%). Carcinoid syndrome (flushing, diarrhea, bronchospasm) is extremely rare in appendiceal carcinoids because serotonin reaches the liver via the portal vein and is inactivated by monoamine oxidase (first-pass effect) — only with liver metastasis does serotonin reach the systemic circulation.
Well-defined, homogeneously intensely enhancing small solid nodule at the appendiceal tip (distal end) — the signature finding of appendiceal carcinoid. Because enterochromaffin cells are most concentrated in the distal submucosa, 70-80% of tumors occur at this location. Prominent arterial phase enhancement reflects the rich capillary network of the neuroendocrine tumor. This combination of location and enhancement pattern is specific to carcinoid among appendiceal neoplasms — mucinous neoplasm is cystic, and adenocarcinoma is typically base/body-located with heterogeneous enhancement.
Well-defined, round/oval, homogeneously intensely enhancing solid nodule at the appendiceal tip (distal end). Size usually <2 cm (mean 8-10 mm). Enhancement level is markedly higher than surrounding appendiceal wall. The nodule may obstruct the appendiceal lumen causing secondary appendicitis findings proximally.
Report Sentence
A well-defined, homogeneously intensely enhancing solid nodule measuring approximately ___ mm at the distal appendiceal tip is identified in the arterial phase, consistent with appendiceal carcinoid tumor.
Enhancement persists in the portal venous phase but may be slightly decreased compared to the arterial phase. Persistent enhancement reflects contrast retention in the rich capillary network of the neuroendocrine tumor. Washout is typically absent — this feature is important in differentiating from aggressive malignant tumors.
Report Sentence
The nodule demonstrates persistent enhancement in the portal venous phase without washout; this pattern is consistent with a well-differentiated neuroendocrine tumor.
When the carcinoid tumor obstructs the appendiceal lumen, proximal appendiceal dilatation (>6 mm), periappendiceal fat stranding, and wall thickening develop — secondary (obstructive) appendicitis presentation. Appendicolith is usually absent in this setting. The tumor itself may appear isodense on non-contrast CT or may be missed due to its small size.
Report Sentence
A solid lesion in the distal appendix with proximal secondary appendicitis findings (dilatation, fat stranding) is identified; in the absence of appendicolith, obstructive etiology (carcinoid tumor) should be considered in the differential diagnosis.
Solid nodule with intermediate-to-high signal intensity on T2-weighted images at the appendiceal tip. T2 hyperintensity is related to the cellular structure and mildly increased water content of the tumor. Isointense or mildly hypointense appearance on T1-weighted images. On fat-suppressed sequences, the tumor is easily distinguished from surrounding fat tissue.
Report Sentence
A solid nodule with intermediate-to-high T2 signal intensity and T1 isointensity at the distal appendiceal tip is identified, consistent with neuroendocrine tumor.
Hypoechoic, solid, well-defined nodule in the appendiceal tip region. The nodule usually appears slightly more hypoechoic than the surrounding appendiceal wall. Increased vascularity on color Doppler. May be seen with a non-compressible appendix on compression US. In most cases, the carcinoid itself is not recognized on US performed with an appendicitis preliminary diagnosis, but focal thickening/nodule at the appendiceal tip should be noted.
Report Sentence
A hypoechoic, solid, hypervascular nodule on Doppler measuring approximately ___ mm in the appendiceal tip region is identified; appendiceal carcinoid tumor should be considered.
Punctate or coarse calcification may be seen within the tumor — incidence 10-15%. Calcifications are usually centrally located and related to psammoma bodies or dystrophic calcification. Presence of calcification supports the diagnosis but is not pathognomonic.
Report Sentence
Punctate calcifications within the solid nodule at the appendiceal tip are identified, representing a supportive finding for neuroendocrine tumor.
Criteria
Size <1 cm, confined to appendiceal wall (submucosa/muscularis), Ki-67 <2%, mitosis <2/10 HPF.
Distinct Features
Majority fall in this group (60-80%). Simple appendectomy sufficient. Metastasis risk <2%. 5-year survival >99%. Follow-up usually not required. Often incidental or too small to detect on CT.
Criteria
Size 1-2 cm. High risk if mesoappendix invasion, lymphovascular invasion, deep muscularis/subserosal invasion, or Ki-67 >2% present.
Distinct Features
Treatment decision personalized based on risk factors. If no risk factors, appendectomy sufficient; if risk factors present, right hemicolectomy recommended. Detectable on CT, usually seen as homogeneously enhancing solid nodule. Metastasis risk 3-10%.
Criteria
Size >2 cm. Regardless of size: cecal base invasion, positive surgical margin, lymph node metastasis.
Distinct Features
Right hemicolectomy mandatory. May show larger size and sometimes heterogeneous enhancement on CT. Mesenteric lymph node and liver metastasis should be screened. Metastasis risk 10-30%. Octreotide scintigraphy or Ga-68 DOTATATE PET-CT used for staging. Long-term follow-up (at least 10 years) required.
Criteria
Mixed tumor showing both neuroendocrine and glandular differentiation. May progress to adenocarcinoma ex-goblet cell carcinoid.
Distinct Features
More aggressive course than classic carcinoid — right hemicolectomy always indicated. May be indistinguishable from classic carcinoid on CT. Higher risk of peritoneal spread (especially in women). Prognosis between classic carcinoid and adenocarcinoma — 5-year survival ~80%. Systemic chemotherapy may be required.
Distinguishing Feature
Appendicitis shows diffuse wall thickening and periappendiceal fat stranding without a focal solid nodule. Carcinoid shows a focal homogeneously enhancing nodule at the tip, and secondary appendicitis findings may accompany.
Distinguishing Feature
Mucinous neoplasm shows cystic/mucinous dilated appendix (low density, thin wall); carcinoid appears as a solid, hypervascular nodule. Calcification in mucinous neoplasm may be wall-based, while in carcinoid it is within the nodule.
Distinguishing Feature
Adenocarcinoma is typically base/body-located, heterogeneously enhancing, infiltrative mass. Carcinoid is a tip-located, well-defined, homogeneously enhancing small nodule. Mucosal destruction and surrounding invasion are more prominent in adenocarcinoma.
Distinguishing Feature
Colorectal (non-appendiceal) carcinoid appears as a submucosal nodule in the rectal or cecal wall. Appendiceal carcinoid is specifically located at the appendiceal tip and is usually smaller in size. Both enhance as hypervascular solid nodules.
Urgency
routineManagement
surgicalBiopsy
Not NeededFollow-up
annualTreatment of appendiceal carcinoid tumor is determined by size and risk factors. <1 cm: Simple appendectomy sufficient, additional treatment or follow-up generally not required. 1-2 cm: Right hemicolectomy if mesoappendix invasion, lymphovascular invasion, positive margin, or high Ki-67; otherwise appendectomy sufficient. >2 cm: Right hemicolectomy always indicated. Staging with CT abdomen/pelvis and if needed octreotide scintigraphy or Ga-68 DOTATATE PET-CT. Carcinoid syndrome screening (24-hour urine 5-HIAA, serum chromogranin A) recommended but rarely positive in appendiceal carcinoids. Overall 5-year survival >95%. Long-term follow-up (annual CT/biochemistry) recommended especially for 1-2 cm and >2 cm groups.
<1 cm: Simple appendectomy is sufficient. 1-2 cm: Right hemicolectomy if mesoappendix invasion, lymphovascular invasion, or high Ki-67 present. >2 cm: Right hemicolectomy indicated. Carcinoid syndrome is extremely rare in appendiceal carcinoids (<1%). Overall 5-year survival >95%.